Crescent Biopharma (CBIO) Other Non-Current Liabilities (2013 - 2021)
Crescent Biopharma (CBIO) reported Other Non-Current Liabilities of $538,587 for Q3 2021, up 199.0% from $180,117 a year earlier and up 31.9% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Other Non-Current Liabilities (2013 - 2021) Analysis & Trends
At the end of FY2020, Crescent Biopharma posted Other Non-Current Liabilities of $264,329.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 1.6% (FY2015 to FY2020).
- By year, Other Non-Current Liabilities came in at $611,623 in FY2018 (-13.5%), $707,003 in FY2017 (-6.2%) and $753,579 in FY2016 (+209.3%).
- The Q3 2021 figure ranks as the highest quarterly Other Non-Current Liabilities since Q4 2018.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q1 2017 (growth of 229.7%); the low point was Q2 2021 (a decline of 20.7%).
- Per Business Quant data, the three quarters before Q3 2021 came in at $408,323 (Q2 2021), $373,911 (Q1 2021) and $264,329 (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Crescent Biopharma | 409.68 Mn | -297.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 538,587.00 |
| Jun 30, 2021 | 408,323.00 |
| Mar 31, 2021 | 373,911.00 |
| Dec 31, 2020 | 264,329.00 |
| Sep 30, 2020 | 180,117.00 |
| Jun 30, 2020 | 515,144.00 |
| Mar 31, 2020 | 393,273.00 |
| Dec 31, 2018 | 611,623.00 |
| Sep 30, 2018 | 732,387.00 |
| Jun 30, 2018 | 750,382.00 |
| Mar 31, 2018 | 767,706.00 |
| Dec 31, 2017 | 707,003.00 |
| Sep 30, 2017 | 801,058.00 |
| Jun 30, 2017 | 813,182.00 |
| Mar 31, 2017 | 824,653.00 |
| Dec 31, 2016 | 753,579.00 |
| Sep 30, 2016 | 922,824.00 |
| Jun 30, 2016 | 880,876.00 |
| Mar 31, 2016 | 250,143.00 |
| Dec 31, 2015 | 243,647.00 |
API Access
Crescent Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();